There are 2789 resources available
Discussion 1522MO and 1523MO
Presenter: Bernd Kasper
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast
Discussion 1524MO and 1525MO
Presenter: Anna Maria Frezza
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast
Discussion 1526MO and 1527MO
Presenter: Olivier Mir
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast
Discussion 1759MO and 60MO
Presenter: Katsuya Tsuchihara
Session: Mini oral session - Translational research
Resources:
Slides
Webcast
Discussion LBA68, 1760MO, 1761MO and 61MO
Presenter: Bertrand Routy
Session: Mini oral session - Translational research
Resources:
Slides
Webcast
LBA52 - Sintilimab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced or metastatic esophageal squamous cell cancer: First results of the phase III ORIENT-15 study
Presenter: Lin Shen
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
LBA53 - Sintilimab plus chemotherapy (chemo) versus chemo as first-line treatment for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (ORIENT-16): First results of a randomized, double-blind, phase III study
Presenter: Jianming Xu
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
962MO - A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells (myDC) in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma
Presenter: Julia Katharina Schwarze
Session: Mini oral session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
963MO - Naxitamab for the treatment of refractory/relapsed high-risk neuroblastoma (HR NB): Updated efficacy and safety data from the international, multicenter phase II trial 201
Presenter: Jaume Mora
Session: Mini oral session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
964MO - Entinostat, nivolumab and ipilimumab in advanced HER2-negative breast cancer (ETCTN-9844)
Presenter: Evanthia Roussos Torres
Session: Mini oral session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast